MedTrace Logo

Fetal Fibronectin as a Predictor of Successful Induction of Mid-trimester Abortion

NCT02694198 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 135

Last updated 2016-05-16

Study results available
· View outcomes & findings →

Summary

Fetal Fibronectin as a Predictor of Successful Induction of Mid-trimester abortion.

Conditions

  • Medical; Abortion, Fetus

Interventions

OTHER

fetal fibronectin measurement

All patients will be put in the dorsal lithotomy position.Using a proper light source and sterile gloves, a sterile speculum free of lubricants will be placed into the vagina before vaginal examination by senior resident and the special Dacron swab from the FFN kit will be used to collect a sample of secretions from the posterior fornix. The sample should be obtained prior to collection of any vaginal wet preparations, before any cervical manipulation or cervical cultures, and if enough amount of fluid (about 2 ml) is not found, vagina will be washed with 2 ml of normal saline.The swab will be placed in sterile plastic containers which will be stored until assayed quantitatively with an Enzyme-Linked Immuno Sorbant Assay.

Sponsors & Collaborators

  • Ain Shams Maternity Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-09-30
Primary Completion
2016-03-31
Completion
2016-03-31

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02694198 on ClinicalTrials.gov